Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardio-oncology Discussion: Primary PCI in Cancer Patients
Author(s): Arjun K Ghosh , Deepak L Bhatt , Cezar Iliescu Added: 2 years ago
Cardio-oncology topic editor, Dr Arjun Ghosh (University College London Hospital and Hatter Cardiovascular Institute, UK) is joined by Dr. Deepak L. Bhatt (Brigham and Women's Hospital, Medical School, US) and Dr Cezar Iliescu(The University of Texas MD Anderson Cancer Center, US) to discuss interventional issues in cancer patients with a focus on patients with acute coronary syndromes (ACS)… View more

Intervention

CV Disease in Special Populations
ESC 23: The RIGHT Study
Author(s): Yan Yan , Gilles Montalescot Added: 7 months ago
ESC 23 — Dr Yan Yan (Beijing Anzhen Hospital, CN) and Prof Gilles Montalescot (Pitie Salpetriere APHP University Hospital,FR) discusses the findings from a comparison of anticoagulation prolongation vs no anticoagulation in STEMI patients post-primary PCI (RIGHT) (NCT03664180). The RIGHT study (Beijing Anzhen Hospital) aimed to evaluate the clinical efficacy and safety of anticoagulation… View more

Anticoagulation

MI/ACS
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 5 months ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
Clot Management in Primary PCI: Fighting Your Enemy
Author(s): Kin Lam Tsui Added: 1 year ago

MI/ACS

Intervention
Andrew
Job title: Interventional Cardiologist
Dr Andrew Luckingis an InterventionalCardiologistat the John Radcliffe Hospital, Oxford. He has extensive experience in cardiac catheterization and intervention, primaryPCI,CTO, and intravascular imaging with IVUS and OCT. DrLucking has a well-established background in clinical research in interventional cardiology and is an expert in inflammatory mediators, thrombosis, and vascular injury… View more
Prof Jacek Legutko is an Interventional Cardiologist at Jagiellonian University Medical College, Head of the Clinical Department of Interventional Cardiology, John Paul II Hospital in Krakow and Chair of the Scientific Congress Committee of the Polish Cardiac Society. Prof Jacek Legutko's main research interest is primary PCI in acute myocardial infarction, intravascular imaging and physiology… View more
Research Area(s) / Expertise:

Expertise

MI/ACS
Job title: Senior Consultant Cardiologist and Head of Interventional Cardiology Services
Dr Ho Hee Hwa graduated from the University of Hong Kong in 1997 and completed his cardiology training in Queen Mary Hospital in 2004. He undertook an Interventional Cardiology Fellowship program in 2006 at New York Presbyterian Weill-Cornell Hospital, USA. Dr Ho joined the Department of Cardiology, Tan Tock Seng Hospital, Singapore in 2010. He is currently a Senior Consultant Cardiologist… View more
ESC 23: MULTISTARS AMI Trial
Author(s): Barbara Stähli Added: 7 months ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275). MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST… View more

MI/ACS

Intervention
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions. What late-breaking trials should we look out for? Which results are likely to impact your practice? What are the considerations and challenges? Trials covered in detail include: 37s:… View more

Standards & Guidelines

Heart Failure
COVID-19 and AMI/PCI in SE Asia and the Middle East
Author(s): Paul Jie Wen Tern , Yilin Jiang , Yee How Lau , et al Added: 2 years ago

MI/ACS